Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Other financing activities (2020 - 2023)

Inmune Bio (INMB) has disclosed Other financing activities for 4 consecutive years, with $1.9 million as the latest value for Q3 2023.

  • Quarterly Other financing activities fell 2.58% to $1.9 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Sep 2023, up 7.92% year-over-year, with the annual reading at $4.8 million for FY2021, 54.11% up from the prior year.
  • Other financing activities hit $1.9 million in Q3 2023 for Inmune Bio, up from $1.9 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.9 million in Q3 2022 to a low of $681000.0 in Q2 2020.
  • Historically, Other financing activities has averaged $1.3 million across 4 years, with a median of $1.5 million in 2021.
  • Biggest five-year swings in Other financing activities: skyrocketed 145.25% in 2022 and later decreased 2.58% in 2023.
  • Year by year, Other financing activities stood at $703000.0 in 2020, then surged by 116.5% to $1.5 million in 2021, then rose by 27.4% to $1.9 million in 2022, then fell by 2.58% to $1.9 million in 2023.
  • Business Quant data shows Other financing activities for INMB at $1.9 million in Q3 2023, $1.9 million in Q2 2023, and $1.7 million in Q1 2023.